topic

Urinary diversion after pelvic exenteration for gynecologic malignancies
Carlos Martínez-Gómez, Martina Aida Angeles, Alejandra Martinez, Bernard Malavaud, Gwenael Ferron

International Journal of Gynecologic Cancer Nov 2020, ijgc-2020-002015; DOI: 10.1136/ijgc-2020-002015
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti, Maria Gabriella Ferrandina, Giuseppe Vizzielli, Tina Pasciuto, Francesco Fanfani, Valerio Gallotta, Pasquale Alessandro Margariti, Vito Chiantera, Barbara Costantini, Salvatore Gueli Alletti, Francesco Cosentino, Giovanni Scambia

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1657-1664; DOI: 10.1136/ijgc-2020-001640
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
Irina Tsibulak, Elisabeth Reiser, Gerhard Bogner, Edgar Petru, Johanna Hell-Teutsch, Alexander Reinthaller, Cornelia Weirather, Tatjana Weiss, Szabolcs Bozsa, Barbara Puschacher, Mirijam Hall, Doris Hittler, Katharina Hrauda, Elisabeth Thell, Sabine Clauss, Johanna Pozniak, Sebastian Alicke, Daniela Gangl, Gottfried Gamperl, Christoph Ebner, Katharina Knoll, Katharina Leitner, Andrea Schilcher, Marina Schinnerl, Verena Sigl, Christian Singer, Thomas Aigmüller, Birgit Hofstätter, Christian Marth

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1667-1671; DOI: 10.1136/ijgc-2020-001975
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
Michele Bartoletti, Roberta Mazzeo, Marco De Scordilli, Anna Del Fabro, Maria Grazia Vitale, Lucia Bortot, Milena Sabrina Nicoloso, Serena Corsetti, Marta Bonotto, Simona Scalone, Giorgio Giorda, Roberto Sorio, Claudia Andreetta, Maria Luisa Meacci, Rocco De Vivo, Gianpiero Fasola, Francesco Sopracordevole, Fabio Puglisi

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1672-1677; DOI: 10.1136/ijgc-2020-001771
HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
Berit Andersen, Sisse Helle Njor, Anne Marie Schak Jensen, Tonje Johansen, Ulla Jeppesen, Hans Svanholm

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1678-1683; DOI: 10.1136/ijgc-2020-001457
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, Peter H Sykes, Ewa Zotow, Samantha Harrison

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1748-1756; DOI: 10.1136/ijgc-2020-001403
BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral
Sabrina Piedimonte, Joanne Power, William D Foulkes, Evan Weber, Laura Palma, Alicia Schiavi, Enza Ambrosio, Rea Konci, Lucy Gilbert, Kris Jardon, Laurence Baret, Xing Zeng

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1757-1761; DOI: 10.1136/ijgc-2020-001261
Base rate of ovarian cancer on algorithms in patients with a pelvic mass
Anne Lone Denny Rolfsen, Alv A Dahl, Are Hugo Pripp, Anne Dørum

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1775-1779; DOI: 10.1136/ijgc-2020-001416
Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study
Steven Fleming, Tamara Jones, Monika Janda, Dimitrios Vagenas, Leigh Ward, Hildegard Reul-Hirche, Carolina Sandler, Andreas Obermair, Sandra Hayes

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1784-1790; DOI: 10.1136/ijgc-2020-001543
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
Michelle McMullen, Katherine Karakasis, Bienvenu Loembe, Emma Dean, Graem Parr, Amit M Oza

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1824-1828; DOI: 10.1136/ijgc-2020-001694

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages